Prostate Cancer - Results from #22920

The future of systemic therapies for localised prostate cancer - Abstract June 18, 2013

Bone markers for monitoring efficacy in patients with bone metastases receiving zoledronic acid: A review of published data - Abstract June 18, 2013

Robot-assisted laparoscopic radical prostatectomy after heart transplantation - Abstract June 18, 2013

A review of tasquinimod in the treatment of advanced prostate cancer - Abstract June 18, 2013

Patients' perceptions of radical prostatectomy for localized prostate cancer: A qualitative study - Abstract June 18, 2013

A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraints - Abstract June 18, 2013

Hemosepermia after transrectal ultrasound-guided prostatic biopsy: A prospective study - Abstract June 18, 2013

Secondary circulating prostate cells predict biochemical failure in prostate cancer patients after radical prostatectomy and without evidence of disease - Abstract June 18, 2013

Racial differences in social support and coping among family caregivers of patients with prostate cancer - Abstract June 18, 2013

Prostate cancer risk in rre-diabetic men: A matched cohort study - Abstract June 18, 2013

High dose rate brachytherapy as monotherapy for localised prostate cancer: A hypofractionated two-implant approach in 351 consecutive patients - Abstract June 18, 2013

Real-time contrast-enhanced transrectal US-guided prostate biopsy: Diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings - Abstract June 17, 2013

Can delayed time to referral to a tertiary level urologist with an abnormal PSA level affect subsequent Gleason grade in the opportunistically screened population? - Abstract June 17, 2013

Sentinel lymph node dissection in more than 1200 prostate cancer cases: Rate and prediction of lymph node involvement depending on preoperative tumor characteristics - Abstract June 17, 2013

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: Results of a Compassionate Use Program in The Netherlands - Abstract June 17, 2013

A model for a urology large group prostate cancer ADT/bone-health clinic - A conversation with Leanne Schimke, CRNP, CUNP June 17, 2013

ASCO 2013 - Slide Lecture: Prognosis and prediction of outcomes in castration-resistant prostate cancer June 17, 2013

Johnson & Johnson announces definitive agreement to acquire Aragon Pharmaceuticals, Inc June 17, 2013

ASCO 2013 - Slide Lecture: Effect of corticosteroid use at baseline on overall survival in patients receiving abiraterone acetate: Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer post-docetaxel June 17, 2013

Role of immunotherapy in castration-resistant prostate cancer (CRPC) - Abstract June 14, 2013

Page 1147 of 1436